News | July 17, 2024
Mankind Pharma signs agreement with Takeda to commercialize Vonoprazan in India
Vonoprazan is a potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related disorders
Vonoprazan is a potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related disorders
Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones
Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
Selexipag is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension
Directs officials to ensure that challenges hampering their effective implementation are resolved early in coordination with states
Diroximel Fumarate Delayed-Release Capsules is indicated for the treatment of relapsing forms of multiple sclerosis
The approved ANDA is therapeutically equivalent to the reference listed drug product
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
Olverembatinib, a novel drug developed by Ascentage Pharma with support from the National Major New Drug Development program
Subscribe To Our Newsletter & Stay Updated
